Andrew J. Schwab

Director, 10% owner, Skye Bioscience, Inc.; Director, Camp4 Therapeutics Corp

Bought, 12 months

$0.0M

Sold, 12 months

$2.9M

Companies

Latest trade

Sep 23, 2026

Companies

Skye Bioscience, Inc.Director, 10% owner −$0.4M Camp4 Therapeutics CorpDirector −$2.5M

Trades

SKYE Sold 119,379 shares at $1.61 $0.2M Sep 23

SKYE Sold 28,700 shares at $1.65 $0.0M Sep 22

SKYE Sold 33,892 shares at $1.91 $0.1M Sep 16

CAMP Sold 400,000 shares at $4.04 $1.6M Aug 27

CAMP Sold 10 shares at $4.50 $0.0M Aug 24

CAMP Sold 32,018 shares at $4.50 $0.1M Aug 21

CAMP Sold 114,700 shares at $4.54 $0.5M Aug 20

SKYE Sold 7,700 shares at $0.32 $0.0M Aug 20

CAMP Sold 45,147 shares at $4.76 $0.2M Aug 19

SKYE Sold 68,140 shares at $0.35 $0.0M Aug 19

SKYE Sold 300,000 shares at $0.38 $0.1M Aug 18

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.